Serum Institute signs contract for 11 million Covid shots with Centre

The central government has signed a contract with Serum Institute of India (SII) for the supply of 11 million doses of Covishield, the Indian variant of the Oxford-AstraZenaca vaccine.

SII has manufactured the vaccine under licence in India. The country will start its mass inoculation programme against Covid-19 on January 16.

Around 3 crore healthcare and frontline workers will be the first in line to receive the shot.



Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea